You have searched for "Emergency Use"
Showing 1-10 of 841
(Reuters) - The World Health Organization (WHO) and global vaccine charities launched the COVAX programme last April to distribute COVID-19 vaccines to some of the world's poorest people.
Here's a look at the news highlights from Asean countries in the Star-AseanPlus section for Tuesday (April 20)
Philippines' Covid-19 cases rise to 953,106 with 7,379 new infections; a big struggle for hospitals in country
The number of confirmed Covid-19 cases in the Philippines surged to 953,106 after the Department of Health (DOH) reported 7,379 new cases on Tuesday.
The country’s pharmaceutical industry is expanding its production capacity as it gears up to produce 5 billion doses by the end of next yearProviding vaccines to poorer countries could boost Beijing’s influence – but it will first have to prove that its drugs meet international standards
The Philippines has granted emergency use authorisation of Johnson & Johnson and India's Biotech vaccines
The Philippines has granted emergency use authorisation (EUA) to the Johnson & Johnson coronavirus vaccine, as well as India's Covaxin, manufactured by Bharat Biotech, the country’s Food and Drug Administration (FDA) said, reported Sputnik.
NEW YORK: The unprecedented oil inventory glut that amassed during the coronavirus pandemic is almost gone, underpinning a price recovery that’s rescuing producers but vexing consumers.
THE health minister has warned localities to use their Covax-supplied Covid-19 vaccine doses by May 5 or face having them redistributed.
DARPA, a US military research lab, has developed a chip that can continuously test people’s blood for the new coronavirus. The invention is in late-stage testing and could be administered to sailors, researchers say.
HONG KONG: Chinese state-owned Sinopharm plans to inject 30 billion yuan ($4.6 billion) in assets into unit Beijing Tiantan Biological Products Corp Ltd to quickly get its fast-growing vaccine business on the public market, two people told Reuters.